There were 2,180 press releases posted in the last 24 hours and 438,096 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Akari Therapeutics announces new data demonstrating synergistic benefits of nomacopan’s bifunctional C5 and LTB4 inhibitory activity in pemphigoid disease

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image